iBio Inc (NASDAQ:IBIO) price on Friday, May 02, fall -1.94% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $1.01.
A look at the stock’s price movement, the close in the last trading session was $1.03, moving within a range at $0.98 and $1.04. The beta value (5-Year monthly) was 1.022. Turning to its 52-week performance, $6.89 and $0.64 were the 52-week high and 52-week low respectively. Overall, IBIO moved -75.49% over the past month.
iBio Inc’s market cap currently stands at around $9.97 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-09.
Turning to the stock’s technical picture we see that short term indicators suggest on average that IBIO is a 100% Sell. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 2 recommend IBIO as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
IBIO’s current price about -12.35% and -69.70% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 27.51, while 7-day volatility ratio is 22.04% and 23.58% in the 30-day chart. Further, iBio Inc (IBIO) has a beta value of 1.08, and an average true range (ATR) of 0.29. Analysts have given the company’s stock an average 52-week price target of $3.6, forecast between a low of $3.6 and high of $3.6. Looking at the price targets, the low is -256.44% off current price level while to achieve the yearly target high, price needs to move -256.44%. Nonetheless, investors will most likely welcome a -256.44% jump to $3.6 which is the analysts’ median price.
If we refocus on iBio Inc (NASDAQ:IBIO), historical trading data shows that trading volumes averaged 3.33 over the past 10 days and 1.11 million over the past 3 months. The company’s latest data on shares outstanding shows there are 9.87 million shares.
The 5.67% of iBio Inc’s shares are in the hands of company insiders while institutional holders own 27.24% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.93 million on 2025-04-15, giving us a short ratio of 1.39. The data shows that as of 2025-04-15 short interest in iBio Inc (IBIO) stood at 919.9999999999999 of shares outstanding, with shares short rising to 0.85 million registered in 2025-03-14. Current price change has pushed the stock -58.78% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the IBIO stock continues to rise going into the next quarter.
